#VisualAbstract: Empagliflozin Has Cardiorenal Benefits for Chronic Kindey Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this cross-sectional study, Medicare Advantage (MA) beneficiaries had a similar prevalence of obesity, hypertension, hyperlipidemia, and chronic kidney ...
1. In this target trial emulation study, denosumab was associated with an increased risk of major adverse cardiovascular events compared ...
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...
1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. The mean eGFR slope was comparable among patients allocated to sodium bicarbonate and placebo over 24 months. 2. Sodium ...
1. In this cross-sectional study, serum cystatin C levels were similar in both Black and White patients at the same ...
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.